Literature DB >> 21717307

Signal intensity of lanthanum carbonate on magnetic resonance images: phantom study.

Shinichi Nakamura1, Kazuo Awai, Masanori Komi, Kosuke Morita, Tomohiro Namimoto, Yumi Yanaga, Daisuke Utsunomiya, Shuji Date, Yasuyuki Yamashita.   

Abstract

PURPOSE: Lanthanum carbonate (LC) is used to treat hyperphosphatemia. The purpose of this study was to investigate the signal intensity (SI) of LC on magnetic resonance imaging (MRI) scans of phantoms.
MATERIALS AND METHODS: LC tablets were thoroughly ground and mixed with distilled water or edible agar (0.05, 0.25, 0.5, and 2.5 mg/ml) in plastic bottles. Four intact tablets were placed in plastic bottles that did or did not contain distilled water or agar. Two radiologists consensually evaluated T1- and T2-weighted images (WIs) obtained with 1.5- and 3.0-T MRI systems for the SI of unground and ground tablets.
RESULTS: On T1- and T2WI, the SIs of the LC suspensions and the solvents alone were similar; the SIs of unground tablets alone and of the air were also similar. Unground tablets in phantoms filled with solvent exhibited lower SI than the solvent. Ground tablets in suspension were not visualized on MRI or computed tomography. These results remained unchanged regardless of differences in magnetic field strength or the solvent used.
CONCLUSION: Ground LC had no contrast enhancement effect on T1WI; on T2WI it did not affect the SI of the solvent. Unground LC tablets may be visualized as a "filling defect" on MRI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717307     DOI: 10.1007/s11604-010-0557-3

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  11 in total

1.  Subclavian MR arteriography: reduction of susceptibility artifact with short echo time and dilute gadopentetate dimeglumine.

Authors:  M A Neimatallah; T L Chenevert; R C Carlos; F J Londy; Q Dong; M R Prince; H M Kim
Journal:  Radiology       Date:  2000-11       Impact factor: 11.105

2.  An unexpected finding on chest roentgenogram following hemodialysis catheter placement.

Authors:  Swathi Singanamala; David A Roer; Mark A Perazella
Journal:  Semin Dial       Date:  2007-12-11       Impact factor: 3.455

3.  Heavy metal--rely on gut feelings: novel diagnostic approach to test drug compliance in patients with lanthanum intake.

Authors:  Sascha David; Timm Kirchhoff; Hermann Haller; Matthias Meier
Journal:  Nephrol Dial Transplant       Date:  2007-04-10       Impact factor: 5.992

4.  Radio-opaque appearance of lanthanum carbonate in a patient with chronic renal failure.

Authors:  J Pafcugová; M Horácková; M Hrasková; J Forejt; M Szabo; R Pádr
Journal:  Nephrol Dial Transplant       Date:  2008-02-18       Impact factor: 5.992

Review 5.  Magnetism: a primer and review.

Authors:  S Saini; R B Frankel; D D Stark; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1988-04       Impact factor: 3.959

Review 6.  Basic physics of MR contrast agents and maximization of image contrast.

Authors:  R E Hendrick; E M Haacke
Journal:  J Magn Reson Imaging       Date:  1993 Jan-Feb       Impact factor: 4.813

Review 7.  Proton relaxation enhancement.

Authors:  M L Wood; P A Hardy
Journal:  J Magn Reson Imaging       Date:  1993 Jan-Feb       Impact factor: 4.813

8.  Susceptibility artefacts in NMR imaging.

Authors:  K M Lüdeke; P Röschmann; R Tischler
Journal:  Magn Reson Imaging       Date:  1985       Impact factor: 2.546

9.  Magnetic susceptibility tensor anisotropies for a lanthanide ion series in a fixed protein matrix.

Authors:  I Bertini; M B Janik; Y M Lee; C Luchinat; A Rosato
Journal:  J Am Chem Soc       Date:  2001-05-09       Impact factor: 15.419

Review 10.  Lanthanum carbonate.

Authors:  Tracy Swainston Harrison; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more
  1 in total

Review 1.  Lanthanum Carbonate Opacities-A Systematic Review.

Authors:  Jan Kampmann; Nina Pirschel Hansen; Anders Nikolai Ørsted Schultz; Andreas Hjelm Brandt; Frans Brandt
Journal:  Diagnostics (Basel)       Date:  2022-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.